A common polymorphism in pre-microRNA-146a is associated with lung cancer risk in a Korean population.

[1]  I. Umelo,et al.  miR-146a Inhibits Cell Growth, Cell Migration and Induces Apoptosis in Non-Small Cell Lung Cancer Cells , 2013, PloS one.

[2]  Qingwei Wang,et al.  The association of miR-146a rs2910164 and miR-196a2 rs11614913 polymorphisms with cancer risk: a meta-analysis of 32 studies. , 2012, Mutagenesis.

[3]  H. Jeon,et al.  Replication of results of genome‐wide association studies on lung cancer susceptibility loci in a Korean population , 2012, Respirology.

[4]  Shu-Chun Lin,et al.  Association between the rs2910164 polymorphism in pre-mir-146a and oral carcinoma progression. , 2012, Oral oncology.

[5]  Qian Chen,et al.  miR-146a, an IL-1β responsive miRNA, induces vascular endothelial growth factor and chondrocyte apoptosis by targeting Smad4 , 2012, Arthritis Research & Therapy.

[6]  J. Hoeijmakers,et al.  MicroRNAs, the DNA damage response and cancer. , 2011, Mutation research.

[7]  A. Iafrate,et al.  Spectrum of Oncogenic Driver Mutations in Lung Adenocarcinomas from East Asian Never Smokers , 2011, PloS one.

[8]  Jun Wang,et al.  Has-miR-146a polymorphism (rs2910164) and cancer risk: a meta-analysis of 19 case–control studies , 2011, Molecular Biology Reports.

[9]  J. Olson,et al.  A functional polymorphism in the pre-miR-146a gene is associated with risk and prognosis in adult glioma , 2011, Journal of Neuro-Oncology.

[10]  Wei Wang,et al.  Polymorphism of the pre-miR-146a is associated with risk of cervical cancer in a Chinese population. , 2011, Gynecologic oncology.

[11]  R. Lidereau,et al.  Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers , 2011, EMBO molecular medicine.

[12]  S. Monticelli,et al.  MiR-146a in Immunity and Disease , 2011, Molecular biology international.

[13]  Gang Xiong,et al.  A functional varient in microRNA-146a is associated with risk of esophageal squamous cell carcinoma in Chinese Han , 2010, Familial Cancer.

[14]  H. Jeon,et al.  Polymorphisms in the Caspase Genes and the Risk of Lung Cancer , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[15]  Wei Zhang,et al.  A functional polymorphism in MSMB gene promoter is associated with prostate cancer risk and serum MSMB expression , 2010, The Prostate.

[16]  Wei Zhang,et al.  A functional polymorphism in Pre‐miR‐146a gene is associated with prostate cancer risk and mature miR‐146a expression in vivo , 2010, The Prostate.

[17]  Xi-sha Chen,et al.  MicroRNA‐146a and Human Disease , 2010, Scandinavian journal of immunology.

[18]  Zhiwei Wang,et al.  miR-146a suppresses invasion of pancreatic cancer cells. , 2010, Cancer research.

[19]  Manel Esteller,et al.  MicroRNAs and cancer epigenetics: a macrorevolution , 2010, Current opinion in oncology.

[20]  Hojoong Kim,et al.  Lung cancer patients who are asymptomatic at diagnosis show favorable prognosis: a korean Lung Cancer Registry Study. , 2009, Lung cancer.

[21]  Hongbing Shen,et al.  A Functional Genetic Variant in microRNA-196a2 Is Associated with Increased Susceptibility of Lung Cancer in Chinese , 2009, Cancer Epidemiology Biomarkers & Prevention.

[22]  K. Jażdżewski,et al.  Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer , 2009, Proceedings of the National Academy of Sciences.

[23]  C. Burge,et al.  Most mammalian mRNAs are conserved targets of microRNAs. , 2008, Genome research.

[24]  Jian-Rong Yang,et al.  A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. , 2008, Carcinogenesis.

[25]  Hua Zhao,et al.  A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. , 2008, Carcinogenesis.

[26]  S. Schokrpur,et al.  Expression of microRNA-146 suppresses NF-κB activity with reduction of metastatic potential in breast cancer cells , 2008, Oncogene.

[27]  Zhenbao Yu,et al.  Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs. , 2008, Carcinogenesis.

[28]  Hongbing Shen,et al.  Genetic variants of miRNA sequences and non-small cell lung cancer survival. , 2008, The Journal of clinical investigation.

[29]  Barbara Jarzab,et al.  Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma , 2008, Proceedings of the National Academy of Sciences.

[30]  M. Lindsay,et al.  Rapid Changes in MicroRNA-146a Expression Negatively Regulate the IL-1β-Induced Inflammatory Response in Human Lung Alveolar Epithelial Cells1 , 2008, The Journal of Immunology.

[31]  Donald C. Chang,et al.  Loss of mir-146a function in hormone-refractory prostate cancer. , 2008, RNA.

[32]  A. Gazdar,et al.  Lung cancer in never smokers — a different disease , 2007, Nature Reviews Cancer.

[33]  M. Fabbri,et al.  Regulatory mechanisms of microRNAs involvement in cancer , 2007, Expert opinion on biological therapy.

[34]  D. Baltimore,et al.  NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses , 2006, Proceedings of the National Academy of Sciences.

[35]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[36]  G. Hannon,et al.  Control of translation and mRNA degradation by miRNAs and siRNAs. , 2006, Genes & development.

[37]  Stijn van Dongen,et al.  miRBase: microRNA sequences, targets and gene nomenclature , 2005, Nucleic Acids Res..

[38]  Eugene Berezikov,et al.  Phylogenetic Shadowing and Computational Identification of Human microRNA Genes , 2005, Cell.

[39]  C. Croce,et al.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.